Ellis Levine, MD, Oncology, Buffalo, NY, Roswell Park Comprehensive Cancer Center

EllisLevineMD

Oncology Buffalo, NY

Hematologic Oncology

Professor of Medicine, SUNY Buffalo

Dr. Levine is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Levine's full profile

Already have an account?

Education & Training

  • University of Minnesota Affiliated HospitalsFellowship, Medical Oncology, 1982 - 1985
  • University of Minnesota at Fairview
    University of Minnesota at FairviewResidency, Internal Medicine, 1979 - 1982
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1979
  • University of Pennsylvania
    University of PennsylvaniaBA, Magna Cum Laude, 1971 - 1975

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1989 - 2022
  • MN State Medical License
    MN State Medical License 1980 - 1989
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Susan G. Komen Hope Award 2018
  • Buffalo Spree Magazine Castle Connolly, 2008-2018
  • America's Top Doctors for Cancer Castle Connolly, 2005-2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study  
    Denysschen CA, Burton H, Ademuyiwa F, Levine E, Tetewsky S, O’Connor T, Eur J Cancer Care, 1/1/2014
  • A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma  
    Hussain M, Daignault S, Agarwal N, Grivas PD, Siefker-Radke AO, Puzanov I, MacVicar GR, Levine EG, Srivivas S, Twardowski P, Eisenberger MA, Quinn DI, Vaishampayan UN,..., Cancer, 1/1/2014
  • Kidney cancer, version 22014  
    Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolgr GB, Chang SS, Choueriri TK, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, L..., J Natl Compr Canc Netw, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Predictors of complete pathological response (pT0) to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC)
    Pokuri VK, Syed JR, Yang Z, Field EP, Pili R, Levine EG, Trump DL, Hutson A, Guru K, George S, Proc Am Soc Clin Oncol, 1/1/2014
  • Secondary breast cancer following hematologic malignancies
    Tanveer F, Ford LA, Wang ES, Levine EG, O’Connor TL, Wetzler M, Proc Am Soc Clin Oncol, 1/1/2014
  • A phase 1b dose-escalation study of TRC105 (anti-endoglin antibody) in combination with capecitabine for advanced solid tumors (including patients with progressive or ...
    Levine EG, Forero A, O’Connor T, Seon BK, Jivani MA, Adams BJ, Theuer CP, Proc Am Soc Clin Oncol, 1/1/2013
  • Join now to see all

Lectures

  • The Evaluation System has Changed: Introduction to the Milestones 
    Roswell Park Cancer Institute, Buffalo, NY - 8/12/2014
  • Managing Treatments’s Side Effects in Advanced Prostate Cancer 
    Buffalo, NY - 8/24/2012
  • Breast Cancer - When to Treat and What to Use? 
    Buffalo, NY - 10/16/2010
  • Join now to see all

Press Mentions

  • Rare Side Effect of Common Chemo Drug, Bleomycin, Leads to Depew Man's Death
    Rare Side Effect of Common Chemo Drug, Bleomycin, Leads to Depew Man's DeathJuly 12, 2019 02:18
  • What Happens if My Cancer Treatment Stops Working?
    What Happens if My Cancer Treatment Stops Working?September 20, 2018 17:55

Grant Support

  • Cooperative Group grants/Lead Academic Participating Site GrantNIH1993–2024

Hospital Affiliations